Source: Annual Congress 2013 –Health economics of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Suijkerbuijk, R. Hoogenveen, A. De Wit, A. Wijga, M. Hoogendoorn, M. Rutten-van Mölken, T. Feenstra (Bilthoven, Rotterdam, Netherlands). Current and future costs of COPD in the Netherlands. Eur Respir J 2013; 42: Suppl. 57, 283

Member's Comments

No comment yet.

Related content which might interest you: Current and future costs of asthma in the Netherlands Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Modeling future COPD epidemiology Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 COPD guideline adherence in hospital- and population-recruited COPD patients Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 A systematic review of models of COPD epidemiology Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Does NICE COPD audit tools affect management of COPD? Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Understanding inequalities in COPD prevention and care policies across Europe Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Predictive value of annual costs on 3-year mortality in COPD Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Global asthma network survey of national asthma strategies – Where are the gaps? Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Cost and effectiveness of 2 years integrated care intervention in COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 The relationship between social deprivation and hospital admissions with asthma Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Cost and effectiveness of integrated care intervention on the patients with COPD Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Healthcare utilization and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 COPD morbidity screening in high risk groups Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Global asthma network identifies gaps in essential asthma medicines Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 LATE-BREAKING ABSTRACT: The use of benzodiazepines in COPD: A population-based study of Norway Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease Year: 2013 COPD readmissions in an urban environment: Health service factors Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Decision analytic models in COPD/asthma: A critical review of current evidence Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Asthma medication use in the general population of West Sweden Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Association of COPD symptomatic burden with healthcare resource utilization and impairment on work and activity Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016 COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013